MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹13,804 Cr | ₹11,907 Cr | ₹9,919 Cr | ₹8,012 Cr | ₹6,735 Cr |
What is the latest Profit & Loss Account Balance ratio of MANKIND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹13,804 Cr |
| Mar2025 | ₹11,907 Cr |
| Mar2024 | ₹9,919 Cr |
| Mar2023 | ₹8,012 Cr |
| Mar2022 | ₹6,735 Cr |
How is Profit & Loss Account Balance of MANKIND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,804 Cr | 15.93 | |
| Mar2025 | ₹11,907 Cr | 20.05 | |
| Mar2024 | ₹9,919 Cr | 23.80 | |
| Mar2023 | ₹8,012 Cr | 18.96 | |
| Mar2022 | ₹6,735 Cr | - | |
Compare Profit & Loss Account Balance of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,783.5 Cr | -0.8% | -6.3% | -12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.8% |
-6.3% |
-12.3% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses